AI-generated summary
The authors retrospectively reviewed adults with scarring alopecia treated with 308-nm excimer laser therapy, mostly as adjunctive treatment. They report that 60% of patients noted subjective improvement after a mean of 3.4 months, with scalp symptoms and inflammatory signs improving and hair density stable. Adverse effects were mild.
- Who or what was studied
- Adults with scarring alopecia, mostly lichen planopilaris or frontal fibrosing alopecia, who had previously received multimodal treatment
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The study is retrospective, so it lacks a control group and the abstract does not give a total patient count.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.